Company Profile

UPL LTD.

NSE : UPLBSE : 512070ISIN CODE : INE628A01036Industry : Pesticides & AgrochemicalsHouse : Rajju Shroff
BSE743.5551.95 (+7.51 % )
PREV CLOSE (Rs.) 691.60
OPEN PRICE (Rs.) 709.85
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 2674105
TODAY'S LOW / HIGH (Rs.)707.55 764.45
52 WK LOW / HIGH (Rs.)336.55 764.45
NSE743.30 51.65 (+7.47 % )
PREV CLOSE(Rs.) 691.65
OPEN PRICE (Rs.) 710.00
BID PRICE (QTY) 743.30 (228 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 57232233
TODAY'S LOW / HIGH(Rs.) 705.05 764.40
52 WK LOW / HIGH (Rs.)336 764.4

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.20
Dividend Yield(%) 1.34
TTM EPS (Rs.) 2.88
P/E Ratio 258.23
Book Value (Rs.) 102.32
Face Value (Rs.) 2
MCap (Rs. in Mn) 568095.83
Price/Earning (TTM) 47.46
Price/Sales (TTM) 5.01
Price/Book (MRQ) 7.27
PAT Margin (%) 4.78
ROCE (%) 8.68
Incorporation Year : 1985

Management Info :

Rajnikant Devidas Shroff - Chairman Rajnikant Devidas Shroff - Managing Director

Registered Office :

Address : 3 - 11 , G I D C,Vapi, ,
Valsad,
Gujarat-396195

Phone : 0260-2400717

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, Luxembourg, MCX
NEWS More
14May05-14-2021$UPL reports 72% rise in Q4 consolidated net profit UPL reports 72% rise in Q4 c

UPL has reported results for fourth quarter and year ended March 31, 2021.

The company has reported net loss at Rs 132 crore for the quarter under review as compared to net loss of Rs 126 crore for the same quarter in the previous year. Total income of the company increased by 30.00% at Rs 2630 crore for Q4FY21 as compared Rs 2023 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 72.28% in its net profit attributed to the Equity holders at Rs 1063 crore for the quarter under review as compared to Rs 617 crore for the same quarter in the previous year. Total income of the company increased by 15.08% at Rs 12845 crore for Q4FY21 as compared Rs 11162 crore for the corresponding quarter previous year.

For the year ended March 31, 2021, the company has reported a fall of 52.28% in its net profit at Rs 220 crore as compared to Rs 461 crore for the previous year. However, total income of the company increased by 12.92% at Rs 11458 crore for year under review as compared to Rs 10147 crore for year ended March 31, 2020.

For the year ended March 31, 2021, on the consolidated basis, the company has reported a rise of 61.66% in its net profit attributed to the owners at Rs 2871 crore as compared to Rs 1776 crore for the previous year. Total income of the company increased by 8.62% at Rs 38952 crore for year under review as compared to Rs 35860 crore for year ended March 31, 2020.

UPL has reported results for fourth quarter and year ended Marc..
14May05-14-2021$UPL zooms on reporting 72% rise in Q4 consolidated net profit UPL zooms on reporting 72% r

UPL is currently trading at Rs. 747.50, up by 55.90 points or 8.08% from its previous closing of Rs. 691.60 on the BSE.

The scrip opened at Rs. 709.85 and has touched a high and low of Rs. 757.60 and Rs. 707.55 respectively. So far 1490445 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 757.60 on 14-May-2021 and a 52 week low of Rs. 336.55 on 20-May-2020.

Last one week high and low of the scrip stood at Rs. 757.60 and Rs. 625.25 respectively. The current market cap of the company is Rs. 57019.69 crore.

The promoters holding in the company stood at 27.96%, while Institutions and Non-Institutions held 53.76% and 10.12% respectively.

UPL has reported results for fourth quarter and year ended March 31, 2021.

The company has reported net loss at Rs 132 crore for the quarter under review as compared to net loss of Rs 126 crore for the same quarter in the previous year. Total income of the company increased by 30.00% at Rs 2630 crore for Q4FY21 as compared Rs 2023 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 72.28% in its net profit attributed to the Equity holders at Rs 1063 crore for the quarter under review as compared to Rs 617 crore for the same quarter in the previous year. Total income of the company increased by 15.08% at Rs 12845 crore for Q4FY21 as compared Rs 11162 crore for the corresponding quarter previous year.

For the year ended March 31, 2021, the company has reported a fall of 52.28% in its net profit at Rs 220 crore as compared to Rs 461 crore for the previous year. However, total income of the company increased by 12.92% at Rs 11458 crore for year under review as compared to Rs 10147 crore for year ended March 31, 2020.

For the year ended March 31, 2021, on the consolidated basis, the company has reported a rise of 61.66% in its net profit attributed to the owners at Rs 2871 crore as compared to Rs 1776 crore for the previous year. Total income of the company increased by 8.62% at Rs 38952 crore for year under review as compared to Rs 35860 crore for year ended March 31, 2020.

UPL is currently trading at Rs. 747.50, up by 55.90 points or 8..
11May05-11-2021$UPL’s arm enters into license agreement with Meiji Seika Pharma UPL’s arm enters into lice

UPL’s subsidiary has entered into a license agreement with Japanese company, Meiji Seika Pharma for exclusive access to Flupyrimin for rice in Southeast Asia. Under the license agreement, UPL will obtain exclusive rights to develop, register and commercialize formulations of Flupyrimin for foliar applications in rice in Southeast Asia, expanding the on-going collaboration between the two companies with this compound. Together, both companies will continue their contributions to the development of differentiated solutions based on Flupyrimin to address farmer pain points and improve their livelihoods.

UPL is global player of crop protection products has customer base in 123 countries. It has subsidiary offices in Argentina, Australia, Bangladesh, Brazil, China, Canada, Denmark, Indonesia, France, Hong Kong, Japan, Korea, Mauritius, Mexico, New Zealand, Russia, Spain, Taiwan, South Africa, USA, UK, Vietnam and Zambia.

UPL’s subsidiary has entered into a license agreement with Ja..
11May05-11-2021$UPL informs about press release UPL informs about press rele
UPL has informed that it enclosed Press Release titled ‘UPL Announces Collaboration with Meiji for Exclusive Access to Flupyrimin Rice in Southeast Asia.'

The above information is a part of company’s filings submitted to BSE.

UPL has informed that it enclosed Press Release titled ‘UPL A..
11May05-11-2021$UPL moves up after its arm enters into license agreement with Meiji Seika Pharma UPL moves up after its arm e

UPL is currently trading at Rs. 675.50, up by 1.10 points or 0.16% from its previous closing of Rs. 674.40 on the BSE.

The scrip opened at Rs. 678.20 and has touched a high and low of Rs. 687.95 and Rs. 668.05 respectively. So far 329261 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 687.95 on 11-May-2021 and a 52 week low of Rs. 336.55 on 20-May-2020.

Last one week high and low of the scrip stood at Rs. 687.95 and Rs. 619.00 respectively. The current market cap of the company is Rs. 52042.03 crore.

The promoters holding in the company stood at 27.96%, while Institutions and Non-Institutions held 53.76% and 10.12% respectively.

UPL’s subsidiary has entered into a license agreement with Japanese company, Meiji Seika Pharma for exclusive access to Flupyrimin for rice in Southeast Asia. Under the license agreement, UPL will obtain exclusive rights to develop, register and commercialize formulations of Flupyrimin for foliar applications in rice in Southeast Asia, expanding the on-going collaboration between the two companies with this compound. Together, both companies will continue their contributions to the development of differentiated solutions based on Flupyrimin to address farmer pain points and improve their livelihoods.

UPL is global player of crop protection products has customer base in 123 countries. It has subsidiary offices in Argentina, Australia, Bangladesh, Brazil, China, Canada, Denmark, Indonesia, France, Hong Kong, Japan, Korea, Mauritius, Mexico, New Zealand, Russia, Spain, Taiwan, South Africa, USA, UK, Vietnam and Zambia.

UPL is currently trading at Rs. 675.50, up by 1.10 points or 0...
Financials More
Rs. in Millions
QTR Mar 21 ANNUAL 21
Net Profit-13202200
Gross Profit -1840 4340
Operating Profit 165017330
Net Sales 26110113450
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
BASF India (BSE)
 2466.60 (1.61%)
M.Cap ( in Cr)
10676.84
Heranba Industries (BSE)
 731.80 (3.54%)
M.Cap ( in Cr)
2928.19
Dhanuka Agritech (BSE)
 888.55 (2.69%)
M.Cap ( in Cr)
4138.72
Astec Lifesciences (BSE)
 1257.45 (1.81%)
M.Cap ( in Cr)
2463.04
PI Industries (BSE)
 2698.40 (0.72%)
M.Cap ( in Cr)
40939.62
Shareholding Pattern More
MUTUAL FUNDS/UTI 4.34 %
PROMOTERS 27.96 %
FI/BANKS/INSURANCE 10.93 %
NON-INSTITUTION 10.12 %
GOVERNMENT 0.1 %
FII 0 %
F & O Quotes